Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 2
1993 1
1994 3
1995 13
1996 30
1997 44
1998 32
1999 46
2000 52
2001 63
2002 77
2003 68
2004 78
2005 75
2006 106
2007 103
2008 85
2009 113
2010 104
2011 124
2012 134
2013 150
2014 142
2015 128
2016 138
2017 141
2018 170
2019 153
2020 214
2021 203
2022 167
2023 142
2024 56

Text availability

Article attribute

Article type

Publication date

Search Results

2,831 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for meloxicam
Your search for neoxicam retrieved no results
Meloxicam.
Khalil NY, Aldosari KF. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:159-197. doi: 10.1016/bs.podrm.2019.10.006. Epub 2019 Dec 12. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164967
Meloxicam, an oxicam derivative: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide, is a nonsteroidal anti-inflammatory drug (NSAID). ...It may also be given by rectal suppository in doses similar to those used orally. The reported …
Meloxicam, an oxicam derivative: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide, is a no …
Mouse Behavior in the Open-field Test after Meloxicam Administration.
Antiorio AT, Alemán-Laporte J, Zanatto DA, Pereira MAA, Gomes MS, Wadt D, Yamamoto PK, Bernardi MM, Mori CM. Antiorio AT, et al. J Am Assoc Lab Anim Sci. 2022 May 1;61(3):270-274. doi: 10.30802/AALAS-JAALAS-21-000046. Epub 2022 Jan 31. J Am Assoc Lab Anim Sci. 2022. PMID: 35101160 Free PMC article.
We previously performed a pilot study to test the antinociceptive activity of meloxicam in mice, but we observed behavioral changes in unoperated control mice. ...One hypothesis for the result was potential differences in formulation between commercial brands of meloxic …
We previously performed a pilot study to test the antinociceptive activity of meloxicam in mice, but we observed behavioral changes i …
[Meloxicam clinical effects].
Shavlovskaya OA, Bokova IA, Shavlovskiy NI. Shavlovskaya OA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):36-42. doi: 10.17116/jnevro202212201136. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35175701 Russian.
Recent studies concern intravenous (i/v) meloxicam (30 mg) administration with moderate and severe postoperative pain syndrome. Today, the most commonly pain therapy scheme using meloxicam includes step-by-step administration of injectable and oral forms: meloxic …
Recent studies concern intravenous (i/v) meloxicam (30 mg) administration with moderate and severe postoperative pain syndrome. Today …
Bupivacaine/Meloxicam Prolonged Release: A Review in Postoperative Pain.
Blair HA. Blair HA. Drugs. 2021 Jul;81(10):1203-1211. doi: 10.1007/s40265-021-01551-9. Epub 2021 Jul 6. Drugs. 2021. PMID: 34228280 Review.
Prolonged-release (PR; as ascribed in the EU) or extended-release (as ascribed in the USA) bupivacaine/meloxicam (HTX-011; hereafter referred to as bupivacaine/meloxicam PR; Zynrelef()) is a synergistic fixed-dose combination (FDC) of the local anaesthetic bupivacai …
Prolonged-release (PR; as ascribed in the EU) or extended-release (as ascribed in the USA) bupivacaine/meloxicam (HTX-011; hereafter …
Bupivacaine and Meloxicam.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2021 Oct 25;78(21):1922-1929. doi: 10.1093/ajhp/zxab304. Am J Health Syst Pharm. 2021. PMID: 34398228 No abstract available.
Bupivacaine/meloxicam ER: A New Dual-acting Extended-Release Local Anesthetic for Opioid-Sparing Postoperative Pain Management.
Bourn T, Serpa SM. Bourn T, et al. Ann Pharmacother. 2023 Jan;57(1):71-85. doi: 10.1177/10600280221086639. Epub 2022 May 10. Ann Pharmacother. 2023. PMID: 35536151 Review.
In Phase 2 and Phase 3 clinical trials, bupivacaine/meloxicam ER was compared with bupivacaine HCl, bupivacaine ER, and meloxicam ER with and without scheduled nonopioid multimodal analgesia (MMA) in bunionectomies, herniorrhaphies, total knee arthroplasty and abdom …
In Phase 2 and Phase 3 clinical trials, bupivacaine/meloxicam ER was compared with bupivacaine HCl, bupivacaine ER, and meloxicam …
Clinical evaluation of postoperative analgesia, cardiorespiratory parameters and changes in liver and renal function tests of paracetamol compared to meloxicam and carprofen in dogs undergoing ovariohysterectomy.
Hernández-Avalos I, Valverde A, Ibancovichi-Camarillo JA, Sánchez-Aparicio P, Recillas-Morales S, Osorio-Avalos J, Rodríguez-Velázquez D, Miranda-Cortés AE. Hernández-Avalos I, et al. PLoS One. 2020 Feb 14;15(2):e0223697. doi: 10.1371/journal.pone.0223697. eCollection 2020. PLoS One. 2020. PMID: 32059002 Free PMC article.
This study compared the serum biochemical changes and postoperative analgesic effects of paracetamol, meloxicam, and carprofen in bitches submitted to an ovariohysterectomy using the Dynamic Interactive Visual Analog Scale (DIVAS) and Pain Scale of the University of Melbou …
This study compared the serum biochemical changes and postoperative analgesic effects of paracetamol, meloxicam, and carprofen in bit …
Meloxicam-induced capillaritis with positive rechallenge.
Ben Salem C, Chahed F, Sahnoun D, Slim R, Sriha B, Denguezli M. Ben Salem C, et al. Br J Clin Pharmacol. 2023 Nov;89(11):3460-3462. doi: 10.1111/bcp.15892. Epub 2023 Aug 31. Br J Clin Pharmacol. 2023. PMID: 37653568 No abstract available.
2,831 results